These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 17009957)

  • 41. RNA-dependent RNA polymerase of hepatitis C virus: study on inhibition by alpha,gamma-diketo acid derivatives.
    Kozlov MV; Polyakov KM; Filippova SE; Evstifeev VV; Lyudva GS; Kochetkov SN
    Biochemistry (Mosc); 2009 Aug; 74(8):834-41. PubMed ID: 19817682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
    Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
    Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The exploding field of the HCV polymerase non-nucleoside inhibitors: summary of a first generation compounds.
    Tramontano E
    Mini Rev Med Chem; 2008 Oct; 8(12):1298-310. PubMed ID: 18855743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase.
    Lesburg CA; Radfar R; Weber PC
    Curr Opin Investig Drugs; 2000 Nov; 1(3):289-96. PubMed ID: 11249710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
    Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A
    Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-nucleoside inhibitors of the HCV polymerase.
    Sarisky RT
    J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.
    Kozlov MV; Polyakov KM; Ivanov AV; Filippova SE; Kuzyakin AO; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2006 Sep; 71(9):1021-6. PubMed ID: 17009957
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.